Is a complete MGRX research report available?

No complete published report is available for Mangoceuticals, Inc. (MGRX) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Mangoceuticals, Inc. (MGRX)

NASDAQ: MGRX · USD

$0.26

+0.01 (+3.5%)· Recorded snapshot

Market cap	5.7M
Revenue (ttm)	315.2K
Net income (ttm)	-16.3M
EPS (ttm)	-$1.10
Shares out	22.2M
Volume	376,719
Beta	1.98

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 315.2K
Net income (ttm): -16.3M
EPS (ttm): -$1.10
Market cap: 5.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantenere

Metric	Value
Amount currency	USD
CIK code	0001938046
Company name	Mangoceuticals, Inc.
Country	United States
Country code	US
CUSIP number	56270V205
Earnings date	2026-11-13
Earnings time	amc
Employees	3
Employees change	1
Employees growth	50%
Enterprise value	$5.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2021
Industry	Health Information Services
IPO date	2023-03-21
Is primary listing	Yes
Is SPAC	No
ISIN number	US56270V2051
Last 10-K release date	2026-04-01
Last earnings date	2026-08-13
Last refreshed	2026-10-28
Last stock split date	2024-10-16
Last stock split type	Reverse
Market cap	$5.7M
Market cap category	Nano-Cap
Next earnings date	2026-11-13
Options	No
Price	$0.26
Price currency	USD
Sector	Healthcare
SIC code	8090
Stock price date	2026-10-28
Symbol	MGRX
U.S. state	Texas
Website	https://www.mangoceuticals.com

Metric

Value

Amount currency

USD

CIK code

0001938046

Company name

Mangoceuticals, Inc.

Country

United States

Country code

CUSIP number

56270V205

Earnings date

2026-11-13

Earnings time

amc

Employees

Employees change

Employees growth

50%

Enterprise value

$5.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2021

Industry

Health Information Services

IPO date

2023-03-21

Is primary listing

Yes

Is SPAC

ISIN number

US56270V2051

Last 10-K release date

2026-04-01

Last earnings date

2026-08-13

Last refreshed

2026-10-28

Last stock split date

2024-10-16

Last stock split type

Reverse

Market cap

$5.7M

Market cap category

Nano-Cap

Next earnings date

2026-11-13

Options

Price

$0.26

Price currency

USD

Sector

Healthcare

SIC code

8090

Stock price date

2026-10-28

Symbol

MGRX

U.S. state

Texas

Website

https://www.mangoceuticals.com

Metric	Value
Earnings yield	-427.43%
EV/Sales	17.64x
FCF / EV yield	-69.95%
FCF yield	-70.59%
Industry forward P/E	34.7x
P/B ratio	0.36x
P/S ratio	17.48x
Sector forward P/E	23.56x
Sector P/E	50.13x

Metric

Value

Earnings yield

-427.43%

EV/Sales

17.64x

FCF / EV yield

-69.95%

FCF yield

-70.59%

Industry forward P/E

34.7x

P/B ratio

0.36x

P/S ratio

17.48x

Sector forward P/E

23.56x

Sector P/E

50.13x

Metric	Value
Gross margin	54.43%
Operating margin	-4,173.65%
Pretax margin	-4,791.54%
Profit per employee	$-5.4M
Revenue per employee	$105,076
ROA	-46.97%
ROCE	-102.99%
ROE	-95.1%
ROIC	-50.33%
SBC / revenue	2,677.77%

Metric

Value

Gross margin

54.43%

Operating margin

-4,173.65%

Pretax margin

-4,791.54%

Profit per employee

$-5.4M

Revenue per employee

$105,076

ROA

-46.97%

ROCE

-102.99%

ROE

-95.1%

ROIC

-50.33%

SBC / revenue

2,677.77%

Metric	Value
EPS growth quarters	10
EPS growth years	2
Gross profit growth	-45.49%
Gross profit growth (Q)	-50.84%
Gross profit growth 3Y	4.78%
Net income growth quarters	2
Net income growth years	0
Revenue growth	-38.91%
Revenue growth (Q)	-59.1%
Revenue growth (QoQ)	1.32%
Revenue growth 3Y	7.91%
Revenue growth years	0

Metric

Value

EPS growth quarters

EPS growth years

Gross profit growth

-45.49%

Gross profit growth (Q)

-50.84%

Gross profit growth 3Y

4.78%

Net income growth quarters

Net income growth years

Revenue growth

-38.91%

Revenue growth (Q)

-59.1%

Revenue growth (QoQ)

1.32%

Revenue growth 3Y

7.91%

Revenue growth years

Metric	Value
Depreciation and amortization	$1.1M
EBIT	$-13.2M
EBITDA	$-12.1M
EPS	$-1.10
FCF per share	$-0.18
Financing cash flow	$4M
Free cash flow	$-3.9M
Free cash flow minus SBC	$-12.3M
Gross profit	$171,590
Net borrowing	$-86,556
Net cash flow	$127,669
Net income	$-16.3M
Operating cash flow minus SBC	$-12.3M
Operating income	$-13.2M
Revenue	$315,227
Stock-based compensation	$8.4M

Metric

Value

Depreciation and amortization

$1.1M

EBIT

$-13.2M

EBITDA

$-12.1M

EPS

$-1.10

FCF per share

$-0.18

Financing cash flow

$4M

Free cash flow

$-3.9M

Free cash flow minus SBC

$-12.3M

Gross profit

$171,590

Net borrowing

$-86,556

Net cash flow

$127,669

Net income

$-16.3M

Operating cash flow minus SBC

$-12.3M

Operating income

$-13.2M

Revenue

$315,227

Stock-based compensation

$8.4M

Metric	Value
Altman Z-Score	-2.59
Book value per share	$0.70
Debt / equity	0.02
Interest coverage	-20.17
Long-term assets	$13.9M
Long-term liabilities	$250,906
Net cash (debt)	$-50,519
Net cash / market cap	-0.92%
Net debt / equity	0
Piotroski F-Score	2
Property, plant and equipment	$280,538
Shareholders' equity	$12.5M
Tangible book value	$-1.1M
Tangible book value per share	$-0.06
Total assets	$14.2M
Total cash	$228,688
Total debt	$279,207
Total liabilities	$1.6M
WACC	23.32%

Metric

Value

Altman Z-Score

-2.59

Book value per share

$0.70

Debt / equity

0.02

Interest coverage

-20.17

Long-term assets

$13.9M

Long-term liabilities

$250,906

Net cash (debt)

$-50,519

Net cash / market cap

-0.92%

Net debt / equity

Piotroski F-Score

Property, plant and equipment

$280,538

Shareholders' equity

$12.5M

Tangible book value

$-1.1M

Tangible book value per share

$-0.06

Total assets

$14.2M

Total cash

$228,688

Total debt

$279,207

Total liabilities

$1.6M

WACC

23.32%

Metric	Value
Asset turnover	0.02
Current assets	$245,687
Current liabilities	$1.4M
Current ratio	0.18
Net working capital	$-1.4M
Quick ratio	0.16
Working capital	$-1.2M
Working capital turnover	-0.24

Metric

Value

Asset turnover

0.02

Current assets

$245,687

Current liabilities

$1.4M

Current ratio

0.18

Net working capital

$-1.4M

Quick ratio

0.16

Working capital

$-1.2M

Working capital turnover

-0.24

Metric	Value
Buyback yield / dilution	-208.91%
Dividend yield	0%
Shareholder yield	-208.91%

Metric

Value

Buyback yield / dilution

-208.91%

Dividend yield

Shareholder yield

-208.91%

Metric	Value
150-day SMA	$0.41
1D price change	3.55%
1M price change	-44.89%
1M total return	-44.89%
1W price change	-12.98%
1W total return	-12.98%
1Y price change	-88%
1Y return CAGR	-88.02%
1Y total return	-88%
20-day SMA	$0.34
200-day SMA	$0.42
3M price change	-52.71%
3M total return	-52.71%
3Y price change	-97.98%
3Y return CAGR	-72.77%
3Y total return	-97.98%
50-day SMA	$0.39
50-day SMA vs 200-day SMA	50under200
52-week high	$2.41
52-week high date	2025-11-10
52-week low	$0.22
52-week low date	2026-10-27
6M price change	-35.78%
6M total return	-35.78%
All-time high	$65.55
All-time high date	2023-03-21
All-time low	$0.22
All-time low date	2026-10-27
Average true range (ATR)	$0.04
Average volume	576.5K
Beta (1Y)	-0.9
Beta (2Y)	-0.57
Beta (5Y)	1.98
Change from 52-week high	-89.34%
Change from 52-week low	17.91%
Change from all-time high	-99.61%
Change from all-time low	17.91%
Change from open	3.51%
Day's gap	0.04%
Dollar volume	$96,741
High price	$0.26
Low price	$0.25
Monthly RSI	37.18
Open price	$0.25
Position in 52-week range	54.37%
Premarket change	0.4%
Premarket close	$0.25
Premarket price	$0.25
Premarket volume	107
Previous close	$0.25
Price vs 150-day SMA	-36.64%
Price vs 20-day SMA	-25.33%
Price vs 200-day SMA	-38.14%
Price vs 50-day SMA	-33.64%
Relative volume	0.66
Return from IPO open	-99.61%
Return from IPO price	-93.8%
RSI	34.51
Sharpe ratio	-0.37
Sharpe ratio (3Y)	-0.16
Sortino ratio	-0.55
Sortino ratio (3Y)	-0.22
Volume	376.7K
Weekly RSI	35.76
YTD price change	-65.3%
YTD total return	-65.3%

Metric

Value

150-day SMA

$0.41

1D price change

3.55%

1M price change

-44.89%

1M total return

-44.89%

1W price change

-12.98%

1W total return

-12.98%

1Y price change

-88%

1Y return CAGR

-88.02%

1Y total return

-88%

20-day SMA

$0.34

200-day SMA

$0.42

3M price change

-52.71%

3M total return

-52.71%

3Y price change

-97.98%

3Y return CAGR

-72.77%

3Y total return

-97.98%

50-day SMA

$0.39

50-day SMA vs 200-day SMA

50under200

52-week high

$2.41

52-week high date

2025-11-10

52-week low

$0.22

52-week low date

2026-10-27

6M price change

-35.78%

6M total return

-35.78%

All-time high

$65.55

All-time high date

2023-03-21

All-time low

$0.22

All-time low date

2026-10-27

Average true range (ATR)

$0.04

Average volume

576.5K

Beta (1Y)

-0.9

Beta (2Y)

-0.57

Beta (5Y)

1.98

Change from 52-week high

-89.34%

Change from 52-week low

17.91%

Change from all-time high

-99.61%

Change from all-time low

17.91%

Change from open

3.51%

Day's gap

0.04%

Dollar volume

$96,741

High price

$0.26

Low price

$0.25

Monthly RSI

37.18

Open price

$0.25

Position in 52-week range

54.37%

Premarket change

0.4%

Premarket close

$0.25

Premarket price

$0.25

Premarket volume

107

Previous close

$0.25

Price vs 150-day SMA

-36.64%

Price vs 20-day SMA

-25.33%

Price vs 200-day SMA

-38.14%

Price vs 50-day SMA

-33.64%

Relative volume

0.66

Return from IPO open

-99.61%

Return from IPO price

-93.8%

RSI

34.51

Sharpe ratio

-0.37

Sharpe ratio (3Y)

-0.16

Sortino ratio

-0.55

Sortino ratio (3Y)

-0.22

Volume

376.7K

Weekly RSI

35.76

YTD price change

-65.3%

YTD total return

-65.3%

Metric	Value
Float	16.3M
Float percentage	73.27%
Shares change (QoQ)	3.87%
Shares change (YoY)	208.91%
Shares held by insiders	22.38%
Shares held by institutions	5.6%
Shares outstanding	22.2M
Short % of float	2.69%
Short % of shares	1.97%
Short ratio	0.9 days

Metric

Value

Float

16.3M

Float percentage

73.27%

Shares change (QoQ)

3.87%

Shares change (YoY)

208.91%

Shares held by insiders

22.38%

Shares held by institutions

5.6%

Shares outstanding

22.2M

Short % of float

2.69%

Short % of shares

1.97%

Short ratio

0.9 days

Mangoceuticals, Inc. (MGRX)

Price

Financial snapshot

Fair-value bridge

Latest news · MGRX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All MGRX indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on MGRX

Frequently asked questions